Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement 2023, 2023(19): 1598–1695.

Google Scholar 

Jack CR Jr, Scott Andrews J, Beach TG, Buracchio T, Dunn B, Graf A. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement 2024, 20: 5143–5169.

Article  PubMed  PubMed Central  Google Scholar 

Falsetti L, Viticchi G, Zaccone V, Guerrieri E, Moroncini G, Luzzi S, et al. Shared molecular mechanisms among Alzheimer’s disease, neurovascular unit dysfunction and vascular risk factors: A narrative review. Biomedicines 2022, 10: 439.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu ZH, Wang YJ, Bu XL. Alzheimer’s disease: Targeting the peripheral circulation. Mol Neurodegener 2023, 18: 3.

Article  PubMed  PubMed Central  Google Scholar 

Al-Kuraishy HM, Jabir MS, Albuhadily AK, Al-Gareeb AI, Rafeeq MF. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation. Ageing Res Rev 2023, 91: 102084.

Article  PubMed  Google Scholar 

Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet 2024, 404: 572–628.

Article  PubMed  Google Scholar 

Vijayan D, Chandra R. Amyloid beta hypothesis in Alzheimer’s disease: Major culprits and recent therapeutic strategies. Curr Drug Targets 2020, 21: 148–166.

Article  CAS  PubMed  Google Scholar 

Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, et al. β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology 2012, 78: 387–395.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang YL, Wang J, Zhang ZN, Su Q, Guo JH. The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer’s disease. Neural Regen Res 2022, 17: 2355–2363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rostami J, Mothes T, Kolahdouzan M, Eriksson O, Moslem M, Bergström J, et al. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates. J Neuroinflammation 2021, 18: 124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong Y, Liu C, Zhou Y, Qi J, Zhang C, Sun B, et al. Progress of RAGE molecular imaging in Alzheimer’s disease. Front Aging Neurosci 2020, 12: 227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ, et al. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer’s disease animal model. FASEB J 2009, 23: 2639–2649.

Article  CAS  PubMed  Google Scholar 

Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener 2018, 13: 57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roher AE, Esh CL, Kokjohn TA, Castaño EM, Van Vickle GD, Kalback WM, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer’s disease. Alzheimers Dement 2009, 5: 18–29.

Article  CAS  PubMed  Google Scholar 

Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT, et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina. Acta Neuropathol 2020, 139: 813–836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bassendine MF, Taylor-Robinson SD, Fertleman M, Khan M, Neely D. Is Alzheimer’s disease a liver disease of the brain? J Alzheimer’s Dis 2020, 75(1): 1–14. https://doi.org/10.3233/JAD-190848.

Article  CAS  Google Scholar 

Crane A, Brubaker WD, Johansson JU, Trigunaite A, Ceballos J, Bradt B, et al. Peripheral complement interactions with amyloid β peptide in Alzheimer’s disease: 2. Relationship to amyloid β immunotherapy. Alzheimers Dement 2018, 14: 243–252.

Article  PubMed  Google Scholar 

Brubaker WD, Crane A, Johansson JU, Yen K, Garfinkel K, Mastroeni D, et al. Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms. Alzheimers Dement 2017, 13: 1397–1409.

Article  PubMed  Google Scholar 

Carbone MG, Pagni G, Tagliarini C, Imbimbo BP, Pomara N. Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease? Ageing Res Rev 2021, 71: 101420.

Article  CAS  PubMed  Google Scholar 

Inyushin M, Zayas-Santiago A, Rojas L, Kucheryavykh L. On the role of platelet-generated amyloid beta peptides in certain amyloidosis health complications. Front Immunol 2020, 11: 571083.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canobbio I, Catricalà S, Di Pasqua LG, Guidetti G, Consonni A, Manganaro D, et al. Immobilized amyloid Aβ peptides support platelet adhesion and activation. FEBS Lett 2013, 587: 2606–2611.

Article  CAS  PubMed  Google Scholar 

Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M. Clearance of cerebral aβ in Alzheimer’s disease: Reassessing the role of microglia and monocytes. Cell Mol Life Sci 2017, 74: 2167–2201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu ZH, Bai YD, Yu ZY, Li HY, Liu J, Tan CR, et al. Improving blood monocyte energy metabolism enhances its ability to phagocytose amyloid-β and prevents Alzheimer’s disease-type pathology and cognitive deficits. Neurosci Bull 2023, 39: 1775–1788.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, et al. Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol 2011, 122: 401–413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdullah L, Luis C, Paris D, Ait-ghezala G, Mouzon B, Allen E, et al. High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer’s disease patients. Mol Med 2009, 15: 95–100.

Article  CAS  PubMed  Google Scholar 

Donner L, Fälker K, Gremer L, Klinker S, Pagani G, Ljungberg LU, et al. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release. Sci Signal 2016, 9: ra52.

Article  PubMed  Google Scholar 

van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, et al. Systemic and central nervous system metabolic alterations in Alzheimer’s disease. Alzheimers Res Ther 2019, 11: 93.

Article  PubMed  PubMed Central  Google Scholar 

Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, et al. Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules 2016, 6: 6.

Article  PubMed  PubMed Central  Google Scholar 

Biundo F, Del Prete D, Zhang H, Arancio O, D’Adamio L. A role for tau in learning, memory and synaptic plasticity. Sci Rep 2018, 8: 3184.

Article  PubMed  PubMed Central  Google Scholar 

Nam E, Lee YB, Moon C, Chang KA. Serum tau proteins as potential biomarkers for the assessment of Alzheimer’s disease progression. Int J Mol Sci 2020, 21: 5007.

Article  CAS